Resources for coping with cancer during COVID-19. Learn More

What are androgens?

What are androgens?
Androgens are male sex hormones.  The two most common are testosterone and dihydrotestosterone (DHT).  Women have small amounts of androgens too.  Like all hormones, androgens affect the actions of cells and tissues in the body.  Most testosterone is produced in the testicles, but a small amount is made by the adrenal glands (just above the kidneys).  Prostate cancer cells can also produce testosterone.
What do androgens and prostate cancer have to do with each other?
Androgens are needed to ensure that the prostate grows and functions normally.  Androgens can lead to prostate cancer, because they bind to and activate (turn on) the ‘androgen receptor’, a protein that is produced by the cells in the prostate gland.   Once these androgen receptors have been bound to androgen, they then stimulate certain genes that cause prostate cells to grow. 
At early stages of prostate cancer, prostate cancers “feed off” androgens, depending on them to grow.  These types of prostate cancers are known as “androgen-dependent” or “androgen-sensitive”.  Androgen Deprivation Therapy (ADT) works to ‘deprive’ these prostate cells of androgen, thus inhibiting their development.
Unfortunately in men with more advanced cancer, most prostate cancers will eventually continue to grow even when there is a low level of androgens in the body – a phenomenon known as “castration resistant prostate cancer”.

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Canadian Cancer Society and Prostate Cancer Canada celebrate their amalgamation

February 3, 2020 (Toronto, ON) – On the eve of World Cancer Day, the Canadian Cancer Society (CCS) and Prostate Cancer Canada (PCC) have finalized their amalgamation.

1.5 million Canadian men over 50 now at unnecessary risk for prostate cancer

Toronto (ON) – September 26, 2019 – New findings released today in a Prostate Cancer Canada nationwide survey suggest 1.

$2 million invested in new prostate cancer research

Prostate Cancer Canada and Movember partner to fund ten research projects breaking new ground

Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.

Click here for news archive